Polymorphonuclear leukocytes (PMN or neutrophils) have been implicated in the pathogenesis of several acute and chronic lung diseases such as acute respiratory distress syndrome and BPD (1, 2) . During this process, neutrophils recruited into the lung release mediators that are injurious, including proteolytic enzymes, toxic oxygen radicals, and arachidonic acid metabolites (2) . However, it has become evident that neutrophils are more than inflammatory effector cells; they have the ability to amplify the inflammatory response by the release of cytokines (3) (4) (5) (6) (7) . Recent work from our laboratory has demonstrated that the neutrophil of the newborn releases IL-8 in quantities sufficient for the chemotaxis of other neutrophils, that this process is more intense for the newborn versus the adult, and that neutrophil IL-8 release is inhibited by DEX (8) .
NF-B is one of the critical regulatory proteins that control expression of inflammatory genes, including IL-1␤, IL-8, and TNF-␣ (9 -11). The NF-B proteins (p50 NF-B1, p65/Rel A, c-Rel, NF-B2/p52, and Rel B) are retained in the cytoplasm through their association with the inhibitory protein IB-␣. After cell stimulation, NF-B translocates to the nucleus where it activates gene transcription (9 -11) . However, expression and activation of the individual NF-B subunits is cell-specific and appears to be developmentally regulated (12) .
Because the knowledge that neutrophils are an important source of cytokines is relatively new, the molecular mechanisms regulating cytokine expression in these cells have only begun to be investigated (13-16); there are no previous studies in the newborn. The aims of the present study were to deter-extracts containing pepstatin A, bestatin, leupeptin, aprotinin, AEBSF, and E-64 obtained from Sigma Chemical Co. (P-8340) and used in concentrations 60 L/5 ϫ 10 6 cells.] After the addition of 0.1 vol of 10% NP-40, the cells were vortexed (10 s) and immediately centrifuged at 500 ϫ g for 10 min at 4°C. The supernatants were discarded, and the pellets were washed in 200 L of buffer A and recentrifuged. The pelleted nuclei were resuspended in 50 L of ice-cold nuclear buffer (NE buffer: 20 mM HEPES, pH 7.5, 25% glycerol, 500 mM KCl, 1 mM MgCl 2 , 1% NP-40, 1 mM EDTA, 2 mM DTT, 2 mM PMSF) containing the protease inhibitor cocktail (60 L/5 ϫ 10 6 cells). After a 20-min incubation on ice (with occasional mixing), the samples were centrifuged (14,000 ϫ g, 15 min, 4°C), and the resulting supernatants (nuclear extracts) were aliquoted and stored at Ϫ80°C. Protein concentration was measured using the Pierce Coomassie plus protein assay kit (Pierce, Rockford, IL, U.S.A.).
EMSA. The oligonucleotide used as a probe for EMSA was a 42-bp double-stranded construct (5Ј-TTGTTACAAGGG GACTTTCCGCTGGGGACTTTCCAGGGAGGC-3Ј) containing two tandemly repeated NF-B binding sites (underlined). Mutant oligonucleotide used for competition studies was 5Ј-TTGTTACAATCTCACTTTCCGCTTCTCACTTTCCAGGG AGGC-3Ј. End labeling was accomplished by treatment with T4 kinase in the presence of ␥-[ 32 P]ATP, and the labeled oligonucleotide was purified on a Sephadex G-25 column as described elsewhere (19) .
Nuclear extracts (containing 5-7 g of protein, 8 ϫ 10 5 cell equivalent, in 7-10 L) were incubated (20 min at room temperature) with 5-10 fmol of radiolabeled oligonucleotide (approximately 70,000 cpm) in 20 L of binding buffer (20 mM Tris-Cl, pH 7.5, 150 mM KCl, 1 mM EDTA, 1 mM DTT, 0.1% NP-40, 6% glycerol) supplemented with 20 g acetylated BSA and 2 g poly (dI-dC). For competition or supershift experiments, binding reactions were performed in the presence of 30-M excess of unlabeled oligonucleotide or 1 g of specific polyclonal antibody, respectively, and incubated 15 min at room temperature before adding 32 P-labeled oligonucleotide. The resulting complexes were resolved on 5% nondenaturing polyacrylamide gels that had been prerun at 100 V for 30 min in 0.5 ϫ TBE buffer (45 mM Tris, 45 mH boric acid, and 1 mM EDTA, pH 8.0). Electrophoresis was conducted at 180 V for 2.5 h. After electrophoresis, gels were transferred to Whatman DE-81 paper, dried, and exposed to autoradiographic film (Kodak Biomax MS) with intensifier screen at Ϫ80°C. Each gel was exposed to the film for different lengths of time to generate series of images with different intensities. Only the exposures that fell within the linear response of the film were used for digital quantification using image analysis software (UN-SCAN-IT gel Version 5.1 from Silk Scientific, Orem, UT, U.S.A.).
Statistical analysis. Data were expressed as mean Ϯ SEM. The Mann-Whitney test was used to compare TNF-induced activation of NF-B between neutrophils of the newborn versus adult. A p value Ͻ0.05 was considered significant. Data were analyzed by using an InStat software package (Graph-PAD, San Diego, CA, U.S.A.).
258

RESULTS
Characterization of molecular forms of NF-B in neutrophils of the newborn.
To analyze the molecular forms of NF-B in newborn neutrophils, we used EMSA, with an NF-B oligonucleotide containing two tandemly repeated NF-B binding sites. Incubation of a radiolabeled NF-B oligonucleotide with nuclear extracts of TNF-stimulated neutrophils resulted in reduced mobility of two NF-B binding complexes (Fig. 1, lane 1) . To confirm the specificity of the DNA-protein interaction, we performed competition studies with unlabelled oligonucleotides. Addition of a 30-fold excess of unlabeled wild-type NF-B oligonucleotide resulted in complete disappearance of both complexes (lane 2), whereas unlabeled mutant oligonucleotide did not affect either band (lane  3) .
To analyze the subunit composition of these two complexes, we performed a supershift assay using polyclonal antibodies against p50, p65, and c-Rel subunits of NF-B. Antibody to p50 supershifted both bands (Fig. 1, lane 4) , whereas the antibody to p65 supershifted only the slower migrating band (lane 5). Antibody to c-Rel (lane 6) failed to bind to either complex. Moreover, both NF-B complexes were able to bind the inhibitory protein IB-␣ in vitro (lane 7). Figure 1 represents four independent experiments; the same results were also obtained with neutrophils from the adult (data not shown). These results indicate that the slower migrating NF-B complex in TNF-stimulated neutrophils consists of the previously characterized p50/65 heterodimer (13) (14) (15) , whereas the faster migrating NF-B complex represents a newly identified p50/50 homodimer.
Activation of NF-B in neutrophils: newborn versus adult. To investigate activation of the newly identified p50/50 homodimer as well as of the p50/65 heterodimer, neutrophils from newborn and adult were stimulated with TNF, and NF-B DNA binding activities were analyzed in nuclear extracts by EMSA. For both the newborn and the adult, both the p50/65 heterodimers and the p50/50 homodimers were induced by TNF within 15 min, the maximal activation being achieved after 30-min stimulation. Figure 2 is a representative EMSA (n ϭ 7) illustrating NF-B activation in neutrophils from newborn and adult stimulated 30 min with TNF. As expected, only little NF-B DNA binding activity was detected in unstimulated neutrophils. This activity consisted mainly of the p50/50 homodimers; however, after longer film exposures, the p50/65 heterodimer also became visible.
Significantly higher inducibility of both the p50/65 heterodimer and the p50/50 homodimer was detected in TNFstimulated neutrophils of the newborn versus adult (Fig. 2) . Densitometric analysis of scanned images revealed that in the neutrophil of the newborn, the DNA binding activity of the p50/65 heterodimer increased at 30 min approximately 6-fold (samples at t ϭ 30 min were compared with samples at t ϭ 0 min, analyzed on the same gel) (Fig. 3) . In contrast, in the neutrophils from adults, the DNA binding activity of the p50/65 heterodimer increased only 2.5-fold (samples at t ϭ 30 min TNF stimulation were compared with the control samples at t ϭ 0). The p50/50 homodimer was activated approximately 2.8-fold in the newborn and 1.5-fold in the adult.
Activation of NF-B in human neutrophils is inhibited by DEX. To test the hypothesis that DEX suppresses activation of NF-B in human neutrophils, neutrophils from both adult and newborn were preincubated 1 h at 37°C with DEX (10 -7 M, therapeutic range) before stimulation with TNF (2 ng/mL) for 30 min, and nuclear extracts were analyzed for NF-B DNA Figure 4 , pretreatment with DEX (lane 3) reduced activation of both NF-B complexes in TNF-stimulated neutrophils (lane 2). Densitometric analysis revealed that activation of p50/65 heterodimer was inhibited by 50 Ϯ15% (n ϭ 3) in the adult and by 48 Ϯ 12% (n ϭ 3) in the newborn. The p50/50 homodimer was inhibited by 48 Ϯ 12% (n ϭ 3) in the adult, and by 35 Ϯ 9% (n ϭ 3) in the newborn.
DISCUSSION
This is the first study that focuses on the activation of the transcription factor NF-B in neutrophils of the newborn. NF-B plays a central role in the regulation of gene expression underlying production of inflammatory cytokines, enzymes, and adhesion molecules (9 -11). Our results demonstrate for the first time that the faster-migrating NF-B complex in TNF-stimulated neutrophils represents a newly identified p50/50 homodimer, whereas the slower migrating complex consists of the previously characterized p50/65 heterodimer (13) (14) (15) . The p50/65 heterodimer is the classic form of NF-B responsible for induction of inflammatory gene production; the cellular function of p50/50 homodimer is not fully understood (12) . Recently, hyperinduction of p50/50 homodimers has been associated with a repression of transcriptional activation of inflammatory genes and with the induction of lipopolysaccharide tolerance in monocytes and macrophages (20 -23) . One may, therefore, speculate that the p50/50 homodimer activation in the neutrophil may counteract an excessive activation of the p50/65 heterodimer and, thus, represent an important antiinflammatory regulatory mechanism.
Previous studies in our laboratory and others have shown that neutrophils of the newborn have increased ability to synthesize inflammatory cytokines IL-8 and IL-1␤, respectively (8, 24) . However, the molecular mechanisms responsible for the increased expression of inflammatory cytokines by neutrophils of the newborn were not studied. Because the promoter regions of both IL-1␤ and IL-8 contain NF-B binding regulatory sequences (9 -11), we hypothesized that the increased expression of these inflammatory cytokines by neutrophils from the newborn is caused by an increased activation of NF-B that would lead to increased transcription of these cytokines. In this article, we demonstrate that the neutrophil from the newborn exhibits increased activation of NF-B and especially that of p50/65 heterodimer. At present, we do not know the underlying mechanisms responsible for the increased activation of NF-B in the neutrophil of the newborn. One of the critical regulatory steps dictating the kinetics of IB-␣ degradation and NF-B activation are IKK (consisting of the catalytic subunits IKK-␣ and -␤ and the regulatory subunit ␥) and NIK (25) . Therefore, one of the underlying mechanisms responsible for the increased NF-B inducibility in the neutrophil of the newborn may be the increased activation of IKK and/or NIK. Alternatively, the increased NF-B inducibility may be caused by altered degradation of IB-␣. Recent studies demonstrate involvement of ubiquitin-like protein SUMO-1 in a reversible modification of IB-␣ and negative regulation of NF-B activation (26) . In addition, NF-B activation can be regulated at the level of nuclear export of the p50/65 IB-␣ complexes by virtue of nuclear shuttling of IB-␣ (26, 27) . Clearly, the regulation of NF-B activation is more complex than was originally recognized. More studies are needed to dissect the individual pathways regulating NF-B activation in human neutrophils, and studies are currently in progress to identify the exact molecular mechanisms responsible for the increased inducibility of NF-B in the neutrophil of the newborn. Interestingly, our results parallel the studies in human T lymphocytes demonstrating increased activation of NF-B in the newborn versus adult (28) . Given the involvement of NF-B in transcriptional regulation of inflammatory genes (9 -11) , the increased activation of NF-B in the newborn may play a key role in neonatal inflammatory and immunologic reactions.
The increased activity of NF-B in neonatal neutrophil may also represent an important protective mechanism of the newborn against apoptosis. Recent studies indicate that NF-B, and particularly the p65-RelA subunit, exhibits also an antiapoptotic function in TNF-induced cell-death pathways in the neutrophil as well as in other cell types (12, 15) . Interestingly, Allgaier et al. (29) have demonstrated increased resistance of newborn neutrophils to apoptosis compared with those from adults, and they suggested increased expression of antiapoptotic gene(s) in the neutrophils from the newborns.
DEX is an effective but controversial therapy for the safe treatment of chronic lung disease or BPD in newborns (30) . An understanding of the mechanism(s) of DEX antiinflammatory function in newborns with BPD is poorly understood. However, it is established that the neutrophil plays an important role in the pathogenesis of BPD (31) and that the production of IL-8 in neutrophils is inhibited by DEX (8, 32) . Still, there have been no previous studies addressing molecular mechanisms of DEX inhibition of cytokine production in the neutrophil. In this study, we have undertaken the first steps to investigate whether the suppressive effects of DEX on cytokine production in neutrophils are mediated through inhibition of NF-B activation. We demonstrate for the first time that in both newborn and adult neutrophils, DEX (in therapeutic concentration) inhibits activation of both p50/65 and p50/50 NF-B complexes. The molecular mechanisms underlying this NF-B inhibition by DEX in neutrophils are currently under investigation. Studies from other cell types demonstrated two different mechanisms for the NF-B inhibition by DEX (33) (34) (35) . Although in peripheral cells such as monocytes and lymphocytes, glucocorticoids inhibit NF-B activation by enhancing the cellular levels of IB-␣ (36, 37) , in endothelial and epithelial cells, the repressive effects of glucocorticoids are mediated by direct protein-protein interactions between the activated glucocorticoid receptor and the p65 NF-B subunit (38 -41) .
In summary, results of the present study demonstrate an increased TNF-stimulated inducibility of transcription factor NF-B in the neutrophil of the newborn. In addition, we show that this NF-B activation is inhibited by DEX. The increased activation of NF-B in the neutrophils of the newborn likely represents the underlying molecular mechanism of the previously reported elevated production of proinflammatory cytokines IL-8 and IL-1␤ by the newborn (8, 24) . In addition, our results may be related to the increased resistance of the neutrophil of the newborn to apoptosis (29) . Further studies are needed to identify the exact molecular mechanisms responsible for the increased activation of NF-B and its inhibition by DEX in the newborn.
